Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Jefferson University Hospital Using SmartGene Tech to Identify Pathogens

NEW YORK (GenomeWeb News) — Thomas Jefferson University Hospital is using SmartGene's web-based database and software to identify bacteria and fungal pathogens, the company said today.
 
The SmartGene platform identifies pathogens based on genetic sequences by using proofreading, aligning, interpreting gene sequences, and by creating dendrograms and reports.
 
The company said its DNA database allows customers to "more fully utilize their genetic sequence data over time" without using lab instruments and reagent systems.  
 
Donald Jungkind, director of the hospital's Clinical Microbiology Lab in Philadelphia, said the software and database has allowed it to identify a pathogen using its DNA fingerprint, which he said is faster and sometimes more accurate than "conventional identification techniques."
 
Financial terms of the agreement were not disclosed.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more